Clinical Trial Update: Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2 trial update of AMG-386 with pemetrexed and carboplatin in non-small cell lung cancer has completed the indicated phases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AMG-386 (trebananib)
• Alimta (pemetrexed)
• Paraplatin (Carboplatin)

Snippet

Sponsor: Amgen | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED